miscsubjectsAI governance
Evidence review

Selank and GLP-1 Agonist Gut Effects: Evidence on Anxiety Layer and Drug Tradeoffs

· · 4 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `selank-glp1-gut`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/selank-glp1-gut

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/selank-glp1-gut/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/selank-glp1-gut/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/selank-glp1-gut/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/selank-glp1-gut/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have GLP-1 gut damage / gastroparesis

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

This topic: Selank is studied for anxiety-related pathways without classic benzodiazepine sedation. In the regeneration frame: anxiety can follow tissue stress (gut, sleep, stimulant load); Selank research asks whether stabilizing neurochemistry supports recovery rather than only muting feeling.

Why Selank might help you

  1. You are reading about GLP-1 gut damage / gastroparesis — what breaks down matters before any compound name.
  2. What keeps failing: Chronic stress chemistry, stimulant jitter, non-restorative arousal.
  3. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.
  4. Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.

Why GLP-1 agonists (class) matters for you

  1. Drug: GLP-1 agonists (class)
  2. What it does: Metabolic benefit vs gut slowing / muscle loss tradeoffs at rapid weight loss.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • Selank → anxiety / neurochemistry

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 7
  • Claims tagged human evidence: 3
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 7

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.54 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Comparing the risk of gastroparesis following different ... (source s1)

Observational comparison of gastroparesis risk with semaglutide.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Risk of Gastrointestinal Adverse Events Associated With ... (source s5)

Large cohort risk estimates for GLP-1 gastroparesis.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Peptide Selank Enhances the Effect of Diazepam in Reducing ... (source s10)

Russian clinical comparison of Selank anxiolytic activity.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

P-1114 - Rapid and slow response during treatment of ... (source s11)

Selank response kinetics in GAD patients.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Selank for Anxiety: Evidence, Mechanism, Realistic ... (source s12)

Summary of Russian Selank human data and limitations.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

GLP-1 receptor agonists and delayed gastric emptying - PMC (source s19)

Mechanistic review of GLP-1 gastric effects.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Effects of GLP-1 and Its Analogs on Gastric Physiology in ... (source s23)

Human physiology data on GLP-1 gastric slowing.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

GLP-1 agonists · drug map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedSelank: Non-Sedating Anxiolytic · 13 humanSelank for Adderall-Induced Jitteriness and Anxiety · 8 humanSemax, DSIP, and Selank: Evidence Review on Mechanisms Related to Cogn… · 6 humanPT-141 + Selank for SSRI Users: Evidence Review · 3 human
Evidence · 7 sources · swipe →chain 3f9ae15f4287 · verify chain · provenance
1 / 7
Evidence ledger 4 · tier-ranked · API
mechanistic
No human or animal studies test Selank against GLP-1-induced gastroparesis or delayed gastric emptying.
humanlow confidence
GLP-1 agonists increase risk of gastroparesis diagnoses compared with other weight-loss agents in observational human data.
sources: s1, s5
humanlow confidence
Selank showed anxiolytic effects comparable to low-dose benzodiazepines in Russian human GAD trials, with some reports of cognitive enhancement.
sources: s10, s11, s12
humanlow confidence
GLP-1 agonists slow gastric emptying via direct receptor action, contributing to both therapeutic and adverse GI effects.
sources: s19, s23
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 00:44
Selank and GLP-1 Agonist Gut Effects: Evidence on Anxiety Layer and Drug Tradeoffs · 4 claims · 7 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Selank for Glp1 Gut
Slug: selank-glp1-gut
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"GLP-1 gut damage / gastroparesis","condition_key":"glp1-gut-damage","primary_peptide":"selank","peptides_in_scope":[{"id":"selank","name":"Selank"}],"drugs_in_scope":["glp1-agonists"],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":
it output
{"slug":"selank-glp1-gut","title":"Selank and GLP-1 Agonist Gut Effects: Evidence on Anxiety Layer and Drug Tradeoffs","body":"## What's breaking down if you have GLP-1 gut damage / gastroparesis\n\nGLP-1 receptor agonists slow gastric emptying as part of their action on appetite and blood sugar. In some users this leads to persistent delayed emptying that resembles or triggers gastroparesis symptoms such as nausea, bloating, early fullness, and vomiting. Human observational data link the drugs to higher rates of diagnosed gastroparesis compared with other weight-loss agents (human|preclinical). The effect is often dose-dependent and more noticeable early in treatment before partial tachyphylaxis occurs.\n\nChronic gut slowing can also raise background stress signals that feed into the gut-brain axis. If your daily experience includes heightened anxiety or non-restorative arousal on top of the mechanical slowdown, that neurochemistry layer becomes part of what keeps failing.\n\n## Why Selank might help you\n\n1. You are reading about GLP-1 gut damage / gastroparesis — what breaks down matters before any compound name.\n2. What keeps failing: Chronic stress chemistry, stimulant jitter, non-restorative arousal.\n3. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.\n4. Therefore for you: If that layer is part of your problem, Se
ce3c652c55877a3f
Machine verification: /api/articles/selank-glp1-gut/contributions

Related articles

GLP-1 agonists · drug map

Open evidence map →
Semax, DSIP, and Selank: Evidence Review on Mechanisms Related to Cogn…cognitive-stack-adderall-insomniaPT-141 + Selank for SSRI Users: Evidence Reviewpt-141-selank-ssriSelank: Non-Sedating AnxiolyticselankAdderall Amphetamineselank-adderall-amphetamineSelank for Adderall-Induced Jitteriness and Anxietyselank-adderall-jitterinessBenzo Withdrawalselank-benzo-withdrawal
Ask this article · 6 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (mechanistic tier): "No human or animal studies test Selank against GLP-1-induced gastroparesis or delayed gastric emptying."?
ask selank-glp1-gut claim c3 · paste includes §SELF
What does the ledger say about this (human tier): "GLP-1 agonists increase risk of gastroparesis diagnoses compared with other weight-loss agents in observational human data."?
ask selank-glp1-gut claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "Selank showed anxiolytic effects comparable to low-dose benzodiazepines in Russian human GAD trials, with some reports of cognitive enhancem…"?
ask selank-glp1-gut claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "GLP-1 agonists slow gastric emptying via direct receptor action, contributing to both therapeutic and adverse GI effects."?
ask selank-glp1-gut claim c4 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about Selank and GLP-1 Agonist Gut Effects: Evidence on Anxiety Layer and Drug Tradeoffs — and what would you need me to tell you first?
ask selank-glp1-gut condition gaps · paste includes §SELF
What good and bad outcomes are documented for Selank and GLP-1 Agonist Gut Effects: Evidence on Anxiety Layer and Drug Tradeoffs (studies vs anecdotes)?
ask selank-glp1-gut good bad experiences · paste includes §SELF
selank-glp1-gut · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 20890 tokens · $0 · 2 models
chain head cb4fdbbc25845639
write grok/grok-4.3 · 2026-06-30 00:44 · 20890 tok · 2df2a2c0c7ba
voxel_divide owner · 2026-07-17 02:41 · 0 tok · cb4fdbbc2584
verify chain →
Live ledger · 5 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-20 02:36
JCI_CLASSIFY jci · HTTP 200 · 2026-07-19 09:28
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 09:27
PROTOCOL_RUN dispatch · 2026-06-30 00:44 · t_hubqwska
PROTOCOL_RUN dispatch · 2026-06-30 00:44 · t_hubqwska
view full ledger & cards →
REST + ledger
read GET /api/articles/selank-glp1-gut · GET /api/articles/selank-glp1-gut?format=post (the editable body)
create/replace POST /api/articles/selank-glp1-gut · PUT /api/articles/selank-glp1-gut (replace, keeps revision) · PATCH /api/articles/selank-glp1-gut (merge)
delete DELETE /api/articles/selank-glp1-gut
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/selank-glp1-gut/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/selank-glp1-gut/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim selank-glp1-gut|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…